The Society of Nuclear Medicine and Medical Imaging (SNMMI) is praising the U.S. Senate for including neuroendocrine tumors (NETs) in the fiscal year 2025 Senate Defense Appropriations report. NETs are diagnosed and treated with nuclear medicine imaging.
The Senate Appropriations Committee released the report on August 8 and listed NETs as an eligible condition for dedicated research funding through the U.S. Department of Defense’s Congressionally Directed Medical Research Program’s (CDMRP’s) Peer Reviewed Cancer Research Program (PRCRP). The committee recommended that $1.3 million be allocated from the CDMRP's PRCRP, according to the SNMMI.
"SNMMI is encouraged with the inclusion of NETs in the PRCRP and will continue to monitor the appropriations process in the House and Senate," it said.
![Pittsburgh Compound B (PiB) PET distribution volume ratio (DVR) images were projected onto fsaverage surfaces from FreeSurfer and surface smoothed, with PiB (amyloid) slope maps created using ordinary least squares regression (time as only factor) and mixed effects models for 154 participants run at each vertex (P < .01; model: longitudinal Geriatric Depression Scale score estimated by amyloid slope × time + [sex + education + age] × time). This map visualizes the results of the linear mixed-effects models (t score of the main variable, amyloid slope × time) such that regions with a greater t score (red) represent areas in which greater depressive symptoms are associated with greater amyloid accumulation (amyloid slope). Anatomical landmarks are provided: L refers to the left hemisphere, R refers to the right hemisphere, and additional labels indicate the anterior and posterior ends of the brain. Images available for republishing under Creative Commons license (CC BY 4.0 DEED, Attribution 4.0 International) and courtesy of JAMA Open Network.](https://img.auntminnie.com/files/base/smg/all/image/2024/08/PET_depression.66cf997f7e441.png?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
